Pharmacy Practice Review

Depression: supporting quality use of antidepressants

Review your quality use of antidepressants with patients with depression.

  • Cost: free

Depression: Supporting quality use of antidepressants


It is recommended that up to 8 hours of Group 3 CPD (or 24 CPD credits) be recorded for the purposes of self-directed pharmacist CPD.



Depression is common and is estimated to affect 1 in 20 Australians each year.

This activity provides you with an opportunity to reflect on your current management of patients with depression, re-examine treatment options and review the increasing body of evidence supporting a variety of non-pharmacological approaches.

NEW: Express version requires only 5 episodes of care

Choose from:

  1. Express version: 5 episodes of care (for 15 CPD credits), or
  2. Standard version: 10 episodes of care (for 24 CPD credits)

You will be given the option to submit your data once 5 episodes of care are entered, or continue to 10 episodes of care for 16 CPD credits.

Pharmacy Practice Reviews use best practice standards and guidelines to help pharmacists review current practice, consider implementing changes to practice, review and reflect on these changes, and monitor progress.

All participants complete data collection for required episodes of care, receive a feedback report that includes individual results, aggregate results of all participants' practices and an expert commentary on the aggregate results. Participants are provided with a template to record their development and learning plan.


Learning outcomes

Participation in this activity will assist you to:

  • discuss with patients that the use of antidepressants is often part of a broader management plan for depression
  • outline recommended treatment options for patients with depression including adequate trial periods and treatment duration
  • discuss the expectations of antidepressant treatment with patients, explaining potential adverse effects and medicine interactions
  • monitor for adherence and adverse effects, and identify patients that should be referred to their GP or other health service.

You will have access to:

  • up-to-date clinical guidance which provides evidence-based information to update your knowledge and guide your counselling encounters with patients
  • pharmacist tools that inform and support your best practice discussions with patients
  • aggregated results of your peers and expert commentary about the results from Dr Claire O’Reilly (community pharmacist and lecturer, Faculty of Pharmacy University of Sydney).


Pharmacy Practice Review quality assurance poster
Print and display the poster in your pharmacy

Frequently asked questions

Refer to the FAQs for more information.

See the Privacy and confidentiality details.